Atlas Trials

Recurrent Endometrial Clear Cell Adenocarcinoma

5 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Recurrent Endometrial Clear Cell Adenocarcinoma

RecordFirmDate
Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer (NCT04906382)Floor Backes, MD2021-07-01
Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer (NCT03914612)National Cancer Institute (NCI)2019-08-22
VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer (NCT03120624)Mayo Clinic2017-09-15
Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer (NCT00492778)GOG Foundation2008-02-25

Track Recurrent Endometrial Clear Cell Adenocarcinoma automatically

Every clearance here is in the API, with alerts when new ones post.